Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis
- 29 February 1996
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 131 (2), 276-280
- https://doi.org/10.1016/s0002-8703(96)90354-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Subcutaneous Low-Molecular-Weight Heparin Compared With Continuous IntravenoUnfractionated Unfractionated Heparin in the Treatment of Proximal Deep Vein ThrombosisArchives of Internal Medicine, 1993
- Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.Circulation, 1992
- Conjunctive heparin therapy. Limitations of subcutaneous administration.Circulation, 1992
- Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosisThe Lancet, 1992
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Circadian changes in anticoagulant effect of heparin infused at a constant rate.BMJ, 1985